Publications

Communications medicine

Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.

30-09-2025

Nature biotechnology

Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening.

01-02-2025

Nature medicine

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

01-11-2024

Cell reports

Gene and protein sequence features augment HLA class I ligand predictions.

25-06-2024

The New England journal of medicine

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.

06-06-2024

Nature reviews. Clinical oncology

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma.

01-03-2024

Nature biotechnology

Identification of patient-specific CD4⁺ and CD8⁺ T cell neoantigens through HLA-unbiased genetic screens.

01-06-2023

Cancer immunology, immunotherapy : CII

The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.

01-06-2023

Cell reports

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8⁺ T cells.

16-11-2021

Cell

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

29-10-2020

Nature immunology

Author Correction: Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2020

Cell

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.

25-07-2019

The Lancet. Oncology

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

01-07-2019

Nature immunology

Tissue patrol by resident memory CD8⁺ T cells in human skin.

01-06-2019

Nature protocols

Induction of neoantigen-reactive T cells from healthy donors.

01-06-2019

Current opinion in immunology

Neoantigens encoded in the cancer genome.

01-08-2016

Science (New York, N.Y.)

CANCER IMMUNOLOGY. The "cancer immunogram".

06-05-2016

Molecular therapy. Nucleic acids

A Traceless Selection: Counter-selection System That Allows Efficient Generation of Transposon and CRISPR-modified T-cell Products.

22-03-2016

Cell

The Branching Point in Erythro-Myeloid Differentiation.

17-12-2015

Molecular therapy : the journal of the American Society of Gene Therapy

Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor.

01-09-2015

Cancer cell

Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy.

13-07-2015

Cancer cell

Biomarkers in cancer immunotherapy.

12-01-2015

Nature

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

27-11-2014

Journal of immunology (Baltimore, Md. : 1950)

Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

15-11-2014

Science (New York, N.Y.)

T cell memory. Skin-resident memory CD8⁺ T cells trigger a state of tissue-wide pathogen alert.

03-10-2014

Cell reports

Determining lineage pathways from cellular barcoding experiments.

27-02-2014

Chembiochem : a European journal of chemical biology

Development of a hypersensitive periodate-cleavable amino acid that is methionine- and disulfide-compatible and its application in MHC exchange reagents for T cell characterisation.

02-01-2013

Results in immunology

Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

01-01-2012

Annals of the New York Academy of Sciences

The descent of memory T cells.

01-01-2011

Journal of proteomics

Technologies for MHC class I immunoproteomics.

10-09-2010

Nature reviews. Immunology

Mapping the life histories of T cells.

01-09-2010

The Journal of experimental medicine

One naive T cell, multiple fates in CD8+ T cell differentiation.

07-06-2010

Current protocols in immunology

Generation of peptide MHC class I monomers and multimers through ligand exchange.

01-11-2009

Journal of immunology (Baltimore, Md. : 1950)

Requirements for effective antitumor responses of TCR transduced T cells.

01-10-2008

Journal of immunology (Baltimore, Md. : 1950)

Long-term functionality of TCR-transduced T cells in vivo.

15-05-2008

Proceedings of the National Academy of Sciences of the United States of America

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

11-03-2008

Blood

Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease.

01-05-2007

Blood

Targeting self-antigens through allogeneic TCR gene transfer.

01-08-2006

Cellular and molecular life sciences : CMLS

Dissection of cytotoxic and helper T cell responses.

01-12-2005

Clinical cancer research : an official journal of the American Association for Cancer Research

On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients.

15-07-2004

Journal of immunotherapy (Hagerstown, Md. : 1997)

CD8+ T cell tolerance and cancer immunotherapy.

07-01-2003

Nature immunology

Immunotherapy through TCR gene transfer.

01-10-2001

Proceedings of the National Academy of Sciences of the United States of America

Changing T cell specificity by retroviral T cell receptor display.

19-12-2000

Nature immunology

CD27 is required for generation and long-term maintenance of T cell immunity.

01-11-2000

European journal of immunology

Systemic T cell expansion during localized viral infection.

01-04-1999

Current opinion in cell biology

Assembly and intracellular transport of major histocompatibility complex molecules.

01-08-1991

Nature

Peptide selection by MHC class I molecules.

25-04-1991

Cell

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

10-08-1990